Gerresheimer AG - ESG Rating & Company Profile powered by AI
The ESG score includes seventeen UN Sustainable Development Goals including: 'Good Health & Wellbeing', 'Decent Work & Economic Growth' and 'Life on Land'. If you are employed by Gerresheimer AG and you would like to use your Sustainability rating, please get in touch. The assessment of Gerresheimer AG incorporates information from across the internet and also from public documents by Gerresheimer AG.
Gerresheimer AG in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.3; made up of an environmental score of 6.7, social score of 6.9 and governance score of 5.3.
6.3
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
402 | United Laboratories International Holdings Ltd | 6.4 | High |
402 | Zenabis Global Inc | 6.4 | High |
427 | Gerresheimer AG | 6.3 | High |
427 | Calliditas Therapeutics AB | 6.3 | High |
427 | Carna Biosciences Inc | 6.3 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Gerresheimer AG have an accelerator or VC vehicle to help deliver innovation?
Does Gerresheimer AG disclose current and historical energy intensity?
Does Gerresheimer AG report the average age of the workforce?
Does Gerresheimer AG reference operational or capital allocation in relation to climate change?
Does Gerresheimer AG disclose its ethnicity pay gap?
Does Gerresheimer AG disclose cybersecurity risks?
Does Gerresheimer AG offer flexible work?
Does Gerresheimer AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Gerresheimer AG disclose the number of employees in R&D functions?
Does Gerresheimer AG conduct supply chain audits?
Does Gerresheimer AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Gerresheimer AG conduct 360 degree staff reviews?
Does Gerresheimer AG disclose the individual responsible for D&I?
Does Gerresheimer AG disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Gerresheimer AG disclose current and / or historical scope 2 emissions?
Does Gerresheimer AG disclose water use targets?
Does Gerresheimer AG have careers partnerships with academic institutions?
Did Gerresheimer AG have a product recall in the last two years?
Does Gerresheimer AG disclose incidents of discrimination?
Does Gerresheimer AG allow for Work Councils/Collective Agreements to be formed?
Has Gerresheimer AG issued a profit warning in the past 24 months?
Does Gerresheimer AG disclose parental leave metrics?
Does Gerresheimer AG disclose climate scenario or pathway analysis?
Does Gerresheimer AG disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Gerresheimer AG disclose the pay ratio of women to men?
Does Gerresheimer AG support suppliers with sustainability related research and development?
Does Gerresheimer AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Gerresheimer AG reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Gerresheimer AG involved in embryonic stem cell research?
Does Gerresheimer AG disclose GHG and Air Emissions intensity?
Does Gerresheimer AG disclose its waste policy?
Does Gerresheimer AG report according to TCFD requirements?
Does Gerresheimer AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Gerresheimer AG disclose energy use targets?
Does Gerresheimer AG disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Gerresheimer AG have a policy relating to cyber security?
Have a different question?
Potential Risks for Gerresheimer AG
These potential risks are based on the size, segment and geographies of the company.
Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; miniature bottles and glass containers for liquid food, spices, and spirits; and packaging solutions for fragrances, deodorants, skin care, and wellness products, as well as beauty and pharmaceutical products. The Advanced Technologies division develops smart drug delivery systems, such as micro pumps, which are used to self-administer medication for Parkinson's disease or heart failure to pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.